The Infectious Disease Genomics team is focused on the discovery and development of host-response markers to rapidly and accurately diagnose and predict health and disease states. Synergy between multi-disciplinary experts is crucial to tackle the threats posed by infectious diseases and the rise in antimicrobial resistance; potential collaborators are encouraged to contact us.
Systems Pharmacogenomics integrates the science of systems biology with pharmacology, in an effort to gain, at a systems level, “how drugs work." The product of this work is to be able to identify on- and off-target mechanisms for drug action, variation in drug response, adverse drug effects, and reposition drug for novel indications.
About 2.5 million new cases of single seizures and epilepsy occur each year. The unpredictability of seizure occurrence and severity is a major contributor to patient morbidity.